The remarkable low expression of BR3 in atypical B cell subpopulations in addition to the increased frequency of these cells in SLE could explain the decreased expression of BR3 on CD19+ cells in SLE patients reported previously (6, 28, 31, 32). This evidence concerns the gene TNFRSF13C and systemic lupus erythematosus.